Austar Lifesciences Revenue

In the year 2025, Austar Lifesciences had annual revenue of 1.53B CNY with 2.02% growth. Austar Lifesciences had revenue of 868.77M in the half year ending December 31, 2025, with 2.90% growth.

Revenue

1.53B CNY

Revenue Growth

+2.02%

P/S Ratio

0.24

Revenue / Employee

1.06M CNY

Employees

1,446

Market Cap

415.19M HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.53B	30.27M	2.02%
Dec 31, 2024	1.50B	-263.33M	-14.93%
Dec 31, 2023	1.76B	-393.14M	-18.23%
Dec 31, 2022	2.16B	141.84M	7.04%
Dec 31, 2021	2.02B	719.05M	55.48%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sisram Medical	2.84B
Yestar Healthcare Holdings Company	1.66B
Gaush Meditech	1.54B
Vincent Medical Holdings	932.78M
MicroTech Medical (Hangzhou)	482.95M
Venus Medtech (Hangzhou)	468.17M
Shanghai HeartCare Medical Technology Corporation	454.34M
Suzhou Basecare Medical Corporation	302.12M

Revenue Rankings